TY - JOUR T1 - Weather Shocks, Child Mortality, and Adaptation: Experimental Evidence from Uganda JF - medRxiv DO - 10.1101/2023.04.16.23288638 SP - 2023.04.16.23288638 AU - Martina Björkman Nyqvist AU - Tillmann von Carnap AU - Andrea Guariso AU - Jakob Svensson Y1 - 2023/01/01 UR - http://medrxiv.org/content/early/2023/04/24/2023.04.16.23288638.abstract N2 - Background Human-caused climate change is already increasing the intensity and frequency of extreme weather events, such as droughts. The health and economic consequences of these events are expected to be particularly severe for populations in low-income settings whose livelihoods rely on rain-fed agriculture. Within these populations, children are an especially vulnerable group, as undernutrition is linked to 45% of all child deaths across the globe. Despite progress, adaptation gaps exist. We still lack strong evidence on policies to effectively mitigate climate change’s most severe consequences for children. In this paper we ask whether adaptation investments in the form of improved community healthcare can build climate resilience in a low-income country setting.Methods We reanalyzed data from a clustered randomized controlled trial inducing spatial variation across 214 Ugandan villages in community-health program strengthening, and combined it with quasi-experimental data on locality-specific rainfall shocks. In the intervention clusters, financially incentivized community health workers (CHWs) were deployed over a three-year period to conduct home visits and provide integrated community case management and maternal, newborn, and child health treatment and preventive services. The trial followed 7,018 households with young children (3,790 in 115 intervention clusters and 3,228 in 99 control clusters) over three years. We estimated the effect of low rainfall in the growing season on infant mortality in the following (post-harvest and lean) period, conditional on CHW deployment, over six season-pairs in 2011-2013.Findings There were 134 infant deaths in the intervention clusters (38.6 deaths per 1000 infant-years) over the three-year trial period. 60 deaths (40.7 deaths per 1000 infant-years) occurred in periods following growing seasons with rainfall below the long-run detrended mean (rainfall deficit seasons), and 74 deaths (36.8 deaths per 1000 infant-years) occurred in periods following growing seasons rainfall above the long-run detrended mean (rainfall surplus seasons). There were 160 infant deaths in the comparison clusters (61.3 deaths per 1000 infant-years). 83 deaths (81.5 deaths per 1000 infant-years) occurred in periods following rainfall deficit seasons, and 77 deaths (46.3 deaths per 1000 infant-years) occurred in periods following rainfall surplus seasons. Adjusting only for the stratified random assignment of clusters, the mean difference corresponded to a 46% reduction in under-five mortality rate (p=.000; adjusted rate ratio 0.54, 95% CI 0.39-0.73) following rainfall deficit seasons. The risk of infant deaths in the comparison relative to the intervention group increased in the magnitude of the rainfall deficit.Interpretation Adaptation investments in a low-income context – here in the form of improved access to community health care – reduced the risk of infant mortality following adverse weather events.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe trial was registered in the Pan African Clinical Trials Registry (#PACTR201308000601715) and the registration can be accessed online (http://www.pactr.org)Funding StatementThis study and the authors were funded by: Children Investment Fund Foundation (MBN, AG, JS) Riksbankens Jubileumsfond M16:0345:1 (JS) Handelsbankens Forskningsstiftelser P20-0242 (TvC, JS) Mistra, the Swedish Foundation for Strategic Environmental Research (MBN)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial was approved by the ethic committee of Fondazione IRCSS (D2291696), by the Harvard IRB (protocol P20141-101), by the UgandaNational Council for Science and Technology (UNCST) (SS3195), and by the IRB Office of the Joint Clinical Research Center (JCRC) in Uganda.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://www.dropbox.com/s/9fc8w4sp2r33hi0/Supplementary%20material_medrxiv.pdf?dl=0 ER -